Literature DB >> 33954847

Plasma exosomes derived from patients with intestinal Behçet's syndrome induce intestinal epithelial cell pyroptosis.

Cheng-Cheng Hou1, Hai-Fen Ma1, Jing-Fen Ye1, Dan Luo1, Hua-Fang Bao1, Jian-Long Guan2.   

Abstract

OBJECTIVES: Intestinal Behçet's syndrome (IBS) has high morbidity and mortality rates with serious complications. The purpose of this study was to investigate the expression of pyroptosis-related proteins in the intestinal tissues of IBS patients and explore the role of plasma exosomes derived from IBS patients in the pyroptosis of intestinal epithelial cells.
METHOD: Immunohistochemistry was used to investigate the expression of nucleotide-binding domain-like receptor protein 3 (NLRP3), caspase-1, and gasdermin D (GSDMD). Quantitative real-time PCR was employed to measure the mRNA levels of IL-1β and IL-18 in the intestinal tissues. Plasma exosomes were isolated and observed by transmission electron microscopy. The exosomes were co-cultured with intestinal epithelial cells in vitro. Western blot was used to measure the expression of pyroptosis-related proteins including NLRP3, full-length GSDMD, N-terminal GSDMD, pro-caspase-1, and cleaved caspase-1. The levels of IL-1β and IL-18 were detected by enzyme-linked immunosorbent assay. Cell death was measured by using the lactate dehydrogenase (LDH) release assay.
RESULTS: Expression of NLRP3 (12.2% ± 1.2%, 8.1% ± 0.9%, t = 4.692, p = 0.009), caspase-1 (24.6% ± 2.1%, 4.2% ± 1.8%, t = 12.842, p = 0.000), and GSDMD (16.6% ± 1.9%, 9.8% ± 1.3%, t = 5.194, p = 0.007) were significantly increased in the intestinal tissues of patients with IBS compared with normal control (NC) group, respectively. The relative mRNA levels of IL-1β (t = 4.308, p = 0.005) and IL-18 (t = 3.096, p = 0.021) in the intestinal tissues were significantly higher in IBS patients than in NC group, while the protein levels of IL-1β (t = 3.873, p = 0.018) and IL-18 (t = 4.389, p = 0.012) were also significantly increased, which was consistent with the results of the relative mRNA levels. Moreover, we found that exosomes from IBS patients significantly induced pyroptosis of intestinal epithelial cells via the activation of NLRP3 inflammasome in vitro experiments.
CONCLUSIONS: Plasma exosomes derived from IBS patients may induce pyroptosis of intestinal epithelial cells via the activation of NLRP3 inflammasome. Key Points •The role of exosomes in IBS is first reported in this study. • In this study, we explored the mechanism that plasma exosomes derived from IBS patients may induce pyroptosis of intestinal epithelial cells via the activation of NLRP3 inflammasome.

Entities:  

Keywords:  Behçet’s disease; Exosomes; NLRP3 inflammasome; Pyroptosis

Year:  2021        PMID: 33954847     DOI: 10.1007/s10067-021-05755-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

Review 1.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Intestinal Behçet's disease presenting as a massive acute lower gastrointestinal bleed.

Authors:  Jeffrey A Smith; Dabir Siddiqui
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 3.  The role of exosome in autoimmune connective tissue disease.

Authors:  Tian Zhu; Yiman Wang; Hongzhong Jin; Li Li
Journal:  Ann Med       Date:  2019-04-22       Impact factor: 4.709

Review 4.  Role of the NLRP3 inflammasome in autoimmune diseases.

Authors:  Zhe Li; Jialong Guo; Liqi Bi
Journal:  Biomed Pharmacother       Date:  2020-07-29       Impact factor: 6.529

Review 5.  NLRP3: A promising therapeutic target for autoimmune diseases.

Authors:  Hui-Hui Shen; Yue-Xin Yang; Xiang Meng; Xiao-Yun Luo; Xiao-Mei Li; Zong-Wen Shuai; Dong-Qing Ye; Hai-Feng Pan
Journal:  Autoimmun Rev       Date:  2018-05-03       Impact factor: 9.754

Review 6.  Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases.

Authors:  Fangfang Lu; Zhixin Lan; Zhaoqi Xin; Chunrong He; Zimeng Guo; Xiaobo Xia; Tu Hu
Journal:  J Cell Physiol       Date:  2019-10-17       Impact factor: 6.384

Review 7.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics.

Authors:  Karen V Swanson; Meng Deng; Jenny P-Y Ting
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

Review 8.  Behçet's Disease: An Overview of Etiopathogenesis.

Authors:  Pietro Leccese; Erkan Alpsoy
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

9.  Cluster analysis of phenotypes of patients with Behçet's syndrome: a large cohort study from a referral center in China.

Authors:  Jun Zou; Jian-Feng Luo; Yan Shen; Jian-Fei Cai; Jian-Long Guan
Journal:  Arthritis Res Ther       Date:  2021-01-30       Impact factor: 5.156

10.  Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.

Authors:  Kenji Watanabe; Satoshi Tanida; Nagamu Inoue; Reiko Kunisaki; Kiyonori Kobayashi; Masakazu Nagahori; Katsuhiro Arai; Motoi Uchino; Kazutaka Koganei; Taku Kobayashi; Mitsuhiro Takeno; Fumiaki Ueno; Takayuki Matsumoto; Nobuhisa Mizuki; Yasuo Suzuki; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2020-05-07       Impact factor: 7.527

View more
  2 in total

Review 1.  Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.

Authors:  Meini Chen; Rong Rong; Xiaobo Xia
Journal:  J Neuroinflammation       Date:  2022-07-14       Impact factor: 9.587

Review 2.  The Roles of Monocytes and Macrophages in Behçet's Disease With Focus on M1 and M2 Polarization.

Authors:  Lisa Hirahara; Kaoru Takase-Minegishi; Yohei Kirino; Yuki Iizuka-Iribe; Yutaro Soejima; Ryusuke Yoshimi; Hideaki Nakajima
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.